Compare Guardant Health Inc. Common Stock (GH) vs Atlassian Corporation PLC (TEAM) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Guardant Health Inc. Common Stock vs Atlassian Corporation PLC — how do they compare? Guardant Health Inc. Common Stock trades at $167.5 (market cap $22.22B), while Atlassian Corporation PLC trades at $206.85 (market cap $51.53B). The key difference: Atlassian Corporation PLC is far larger — about 2.3× Guardant Health Inc. Common Stock's market cap, and Atlassian Corporation PLC is trading nearer its 52-week high, Guardant Health Inc. Common Stock nearer its low. Which is the better fit depends on your goals — on Pluang, investors hold Guardant Health Inc. Common Stock for 1 Days and Atlassian Corporation PLC for 65 Days on average.
| GH | TEAM | |
|---|---|---|
Market Cap | $22.22B | $51.53B |
Volume | 1,589,453 | 2,904,511 |
Sector | Health | Technology |
52-Week High | $187.22 | $203.57 |
52-Week Low | $61.73 | $57.15 |
Typical Hold Time | 1 Days | 65 Days |
Enterprise Value | $22.86B | $51.52B |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
No Aura AI signal available yet.
Atlassian (TEAM) trades at $206.79, up 5.68% with strong bullish momentum. The stock shows robust technical strength with moving averages signaling buy and price above key resistance levels. Fundamentally, revenue growth continues at $5.22B (2025) with improving margins, though the company remains unprofitable. Recent earnings beats and strong analyst consensus (69.77% buy ratings) support the positive sentiment, while AI-driven product adoption and cloud migration provide growth catalysts.
The outlook remains positive with AI adoption and cloud growth driving momentum, though valuation metrics appear stretched with negative profitability. Key risks include high P/S ratio (8.06), competitive pressures, and execution challenges in maintaining growth trajectory. The consensus price target of $191.16 suggests potential downside from current levels despite strong fundamental improvements.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
No sentiment data available yet.
About Guardant Health Inc. Common Stock
Guardant Health develops blood tests for cancer care. Its tests support genomic profiling, cancer screening, recurrence monitoring, and treatment decisions.
Read more on GH →About Atlassian Corporation PLC
Atlassian produces software that helps teams work together more efficiently and effectively. The company provides project planning and management software, collaboration tools, and IT help desk solutions. The company operates in four segments: subscriptions (term licenses and cloud agreements), maintenance (annual maintenance contracts that provide support and periodic updates and are generally attached to perpetual license sales), perpetual license (upfront sale for indefinite usage of the software), and other (training, strategic consulting, and revenue from the Atlassian Marketplace app store). Atlassian was founded in 2002 and is headquartered in Sydney.
Read more on TEAM →
